trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Antibodies are designed through specific biochemical processes

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Antibodies are routinely designed and engineered using specific biochemical and computational processes to enhance their binding affinity and therapeutic efficacy.

The analysis

The claim states that antibodies are designed through specific biochemical processes, which is strongly supported by literature on antibody engineering, affinity maturation, and computational design (such as papers [2], [3], [4], and [5]). There are no refuting papers.

Evidence for · 4
Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.
Recorded source metadata

Maryam Tabasinezhad, Y. Talebkhan, W. Wenzel, H. Rahimi, E. Omidinia, F. Mahboudi. Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.. 2019. https://doi.org/10.1016/j.imlet.2019.06.009

Discusses how antibody affinity and structure are improved through biochemical and computational maturation processes.

See more details
More for · 3
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Recorded source metadata

Nehad S. El Salamouni, Jordan H. Cater, L. Spenkelink, Haibo Yu. Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. 2024. https://doi.org/10.1002/2211-5463.13850

Details computational modelling and design strategies used to engineer synthetic nanobodies and optimize their binding domains.

Affinity maturation of cross-reactive CR3022 antibody against the receptor binding domain of SARS-CoV-2 via in silico site-directed mutagenesis
Recorded source metadata

Samvedna Saini, M. Agarwal, A. Pradhan, S. Pareek, A. K. Singh, G. Dhawan, Y. Kumar. Affinity maturation of cross-reactive CR3022 antibody against the receptor binding domain of SARS-CoV-2 via in silico site-directed mutagenesis. 2020. https://doi.org/10.21203/rs.3.rs-92745/v1

Presents a protocol for designing affinity-enhancing antibody mutants via in silico site-directed mutagenesis.

Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.
Recorded source metadata

Shi N, Ren C, Zhang L, Wang L, Yang X, Li X, Zhou Y, Wang J, Zhao P, Yao C, Ma Y, Tian J, Huang Q, Xu C, Kuang X, Liu W, Jiang X, Ye J, Gao X, Luo L. Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.. 2026. https://doi.org/10.34133/research.1325

Demonstrates the rational, physics-informed design of nanobodies to optimize interfacial residues and binding affinity.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8601 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt